Josephus H.M. Lange

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers

FLUORO-SUBSTITUTED 3,4-DIARYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDINE DERIVATIVES HAVING CB1-ANTAGONISTIC ACTIVITY

5-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLINES AS CANNABINOID CB1 RECEPTOR AGONISTS

SYNTHESIS OF 3,4-DIARYL-4,5-DIHYDRO-(H)-PYRAZOLE-1-CARBOXAMIDINE DERIVATIVES

Sulphur containing pyrazole derivatives as selective cannabinoid CB receptor antagonists

1H-imidazole derivative having CB, agonistic, CBpartial agonistic or CBantagnistic activity

5-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonists

4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CBreceptor modulators

Compounds with a combination of cannabinoid CBantagonism and serotonin reuptake inhibition

Compounds with a combination of cannabinoid-CBantagonism and acetylcholinesterase inhibition

1 H-imidazole derivatives as cannabinoid receptor modulators

Sulphur containing pyrazole derivatives as selective cannabinoid CBreceptor antagonists

4,5-dihydro-1H-pyrazole derivatives having potent CB-antagonistic activity

4,5-Dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators

Imidazoline derivatives having CB-antagonistic activity

Imidazoline derivatives having CB-antagonistic activity

1H-imidazole derivatives as cannabinoid CB2 receptor modulators

Tetrasubstituted imidazole derivatives as cannabinoid CB receptor modulators with a high CB/CBreceptor subtype selectivity

Imidazoline derivatives having CB1-antagonistic activity

1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

1H-imidazole derivatives as cannabinoid receptor modulators

Thiazole derivatives as cannabinoid receptor modulators

1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity